THE REGENTS OF THE UNIVERSITY OF COLORADO; A BODY CORPORATE
发明人:
CHRISTOPHER R. MARTENS,DOUGLAS R. SEALS
申请号：
US16477639
公开号：
US20200121704A1
申请日:
2018.01.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods of treating subjects suffering from elevated/stage 1 hypertension (formerly “pre-hypertension”) by administering to the subject a therapeutically effective amount of at least one nicotinamide adenine dinucleotide (NAD+) increasing compound, or functional analog, or prodrug, or salt thereof.
